Why More Medical Marijuana IPOs Are Coming

Why More Medical Marijuana IPOs Are Coming and Why You Should Avoid Them

Flickr / GotCredit / (CC BY 2.0)

Almost three months after the initial public offering (IPO) of MedReleaf Corp. (TSX:LEAF), shares have yet to do much in either direction. The company, which came to market in what was then described as a “botched IPO,” fell quickly out of the gate from its IPO price. With potentially many more companies in the medical marijuana IPO pipeline, the entire income statement, including the bottom line, will need to be considered by investors.

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts